Home - Products - Others - Other Targets - Methyl cyclohexanecarboxylate

Methyl cyclohexanecarboxylate

CAS No. 4630-82-4

Methyl cyclohexanecarboxylate ( Hexahydrobenzoic acid methyl ester; Methyl hexahydrobenzoate )

Catalog No. M27564 CAS No. 4630-82-4

Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 36 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl cyclohexanecarboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis.
  • Description
    Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis. Methyl cyclohexanecarboxylate is a flavouring ingredient with berry, estery, and fruity tasting.
  • Synonyms
    Hexahydrobenzoic acid methyl ester; Methyl hexahydrobenzoate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bacterial;β-Lactamase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4630-82-4
  • Formula Weight
    142.2
  • Molecular Formula
    C8H14O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)C1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Arakawa, Yoshichika, et al.β-LACTAMASE INHIBITOR. WO2019221122A1.
molnova catalog
related products
  • JNJ-31020028

    JNJ-31020028 is a selective brain penetrant antagonist of neuropeptide Y2 receptor with high affinity(pIC50=8.07, human; pIC50=8.22 rat).

  • Olumacostat glasaret...

    A small molecule inhibitor of acetyl coenzyme A (CoA) carboxylase (ACC); inhibits de novo lipid synthesis in primary and transformed human sebocytes.

  • RS-127445

    RS-127445 is a selective 5-HT2B receptor antagonist with pKi of 9.5 and pIC50 of 10.4, exhibits >1000-fold selectivity against other 5-HT receptors.